These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 2522162)

  • 1. [New therapeutic possibilities in fulminant viral hepatitis].
    Weiland O; Ericzon BG; Andersson J; Hultcrantz R; Stiernstedt G
    Lakartidningen; 1989 Mar; 86(9):727-9. PubMed ID: 2522162
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of fulminant hepatitis B and fulminant hepatitis B and D coinfection with foscarnet.
    Hedin G; Weiland O; Ljunggren K; Strömberg A; Nordenfelt E; Hansson BG; Oberg B
    Prog Clin Biol Res; 1987; 234():309-20. PubMed ID: 2957702
    [No Abstract]   [Full Text] [Related]  

  • 3. Foscarnet in fulminant hepatitis B.
    Price JS; France AJ; Moaven LD; Welsby PD
    Lancet; 1986 Nov; 2(8518):1273. PubMed ID: 2878146
    [No Abstract]   [Full Text] [Related]  

  • 4. Herpes simplex virus hepatitis in mice: effects of treatment with trisodium phosphonoformate.
    Ulbricht A; Färber I; Wutzler P
    Acta Virol; 1985 Dec; 29(6):493-8. PubMed ID: 2869661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fulminant viral hepatitis.
    Pappas SC
    Gastroenterol Clin North Am; 1995 Mar; 24(1):161-73. PubMed ID: 7729859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved prognosis of fulminant hepatitis by a simple supportive therapeutic regimen.
    Tandon BN; Sharma MP; Tandon RK; Koshy A; Narendranathan M; Mazumdar TN
    Indian J Med Res; 1978 Mar; 67():401-5. PubMed ID: 689714
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical experiences with phosphonoformate (foscarnet) treatment of viral diseases following renal transplantation.
    Ahlmén J; Wijnween AC; Brynger H; Lycke E
    Scand J Urol Nephrol Suppl; 1985; 92():41-4. PubMed ID: 3008316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Foscarnet prophylaxis in marrow transplant recipients.
    Ringden O; Lonnqvist B; Aschan J; Sundberg B
    Bone Marrow Transplant; 1989 Nov; 4(6):713. PubMed ID: 2555006
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of severe hepatitis with artificial liver support system and liver transplantation].
    Wang Y; Dong J; Wang Y; Wang S; Bie P; Liu J; Niu R; He N; Liu G; Li J; Wen H; Luo B
    Zhonghua Gan Zang Bing Za Zhi; 2001 Aug; 9(4):212-3. PubMed ID: 11602050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful liver transplantation in a kidney and pancreas allograft recipient with fulminant herpes simplex virus type 2 hepatitis.
    Ganner A; Lee YM; Busche C; Schmitt-Graeff A; Encke J; Walz G; Gerke P
    Nephrol Dial Transplant; 2007 Nov; 22(11):3334-7. PubMed ID: 17717028
    [No Abstract]   [Full Text] [Related]  

  • 11. Pittsburgh University questions paper.
    Reyes J; Rakela J
    J Okla State Med Assoc; 1995 Aug; 88(8):356. PubMed ID: 7562146
    [No Abstract]   [Full Text] [Related]  

  • 12. Sensitivity of HSV clinical isolates to foscarnet and in vitro dual combination of foscarnet and acyclovir.
    Al-Samarai A; Kinghorn G; Potter C
    Chemioterapia; 1987 Jun; 6(2 Suppl):665-6. PubMed ID: 2855616
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of Foscarnet therapy on infection with human immunodeficiency virus in patients with AIDS.
    Jacobson MA; Crowe S; Levy J; Aweeka F; Gambertoglio J; McManus N; Mills J
    J Infect Dis; 1988 Oct; 158(4):862-5. PubMed ID: 2844921
    [No Abstract]   [Full Text] [Related]  

  • 14. Successful treatment with trisodium phosphonoformate for primary cytomegalovirus infection after heart transplantation.
    Locke TJ; Odom NJ; Tapson JS; Freeman R; McGregor CG
    J Heart Transplant; 1987; 6(2):120-2. PubMed ID: 3040944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exchange transfusion in fulminant hepatitis.
    Koshy A; Singh DS; Tandon BN
    J Assoc Physicians India; 1977 Feb; 25(2):93-9. PubMed ID: 914745
    [No Abstract]   [Full Text] [Related]  

  • 16. Disseminating herpes simplex infection: primary lesions in urinary bladder and successful treatment with forscarnet sodium.
    Blohmé I; Ahlmén J; Jeansson S; Ranch T; Brynger H
    Transplant Proc; 1984 Dec; 16(6):1672-4. PubMed ID: 6239431
    [No Abstract]   [Full Text] [Related]  

  • 17. AIDS: the virus, antivirals and vaccines.
    Weber J
    Br J Hosp Med; 1987 Feb; 37(2):135-7, 140-1. PubMed ID: 2950962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New approaches to treatment of chronic viral hepatitis.
    Holland CC; Wright TL
    Pathology (Phila); 1994; 3(1):23-40. PubMed ID: 9420890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Analysis of prognosis of severe hepatitis].
    He Y; Su XS
    Hunan Yi Ke Da Xue Xue Bao; 2000 Jun; 25(3):285-7. PubMed ID: 12212170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Etiological therapeutics in viral diseases].
    Brochier B; Thiry E; Wérenne J; Schwers A; Vindevogel H; Pastoret PP
    Ann Rech Vet; 1984; 15(1):35-54. PubMed ID: 6207760
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.